Ubs Group Ag Corbus Pharmaceuticals Holdings, Inc. Transaction History

Ubs Group Ag

  • $452 Billion
  • Q3 2024

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 08, 2023
SELL
$0.11 - $5.46 $1,380 - $68,512
-12,548 Reduced 29.52%
29,956 $3,000
Q3 2022

Nov 10, 2022
BUY
$0.17 - $5.31 $6,894 - $215,336
40,553 Added 2078.58%
42,504 $7,000
Q2 2022

Aug 10, 2022
SELL
$0.21 - $0.53 $4,079 - $10,296
-19,428 Reduced 90.87%
1,951 $0
Q1 2022

May 16, 2022
SELL
$0.32 - $0.67 $5,504 - $11,524
-17,201 Reduced 44.59%
21,379 $11,000
Q4 2021

Feb 14, 2022
BUY
$0.6 - $1.11 $16,720 - $30,933
27,868 Added 260.16%
38,580 $24,000
Q3 2021

Nov 15, 2021
SELL
$1.01 - $1.82 $7,184 - $12,945
-7,113 Reduced 39.9%
10,712 $12,000
Q2 2021

Aug 13, 2021
SELL
$1.39 - $2.21 $2,561 - $4,073
-1,843 Reduced 9.37%
17,825 $33,000
Q1 2021

May 12, 2021
BUY
$1.27 - $3.42 $20,580 - $55,421
16,205 Added 467.95%
19,668 $39,000
Q4 2020

Feb 11, 2021
SELL
$0.94 - $1.89 $485 - $975
-516 Reduced 12.97%
3,463 $4,000
Q3 2020

Nov 12, 2020
SELL
$1.5 - $9.38 $255,154 - $1.6 Million
-170,103 Reduced 97.71%
3,979 $7,000
Q2 2020

Jul 31, 2020
BUY
$4.79 - $8.39 $638,669 - $1.12 Million
133,334 Added 327.22%
174,082 $1.46 Million
Q1 2020

May 01, 2020
SELL
$3.44 - $7.21 $159,595 - $334,500
-46,394 Reduced 53.24%
40,748 $214,000
Q4 2019

Feb 14, 2020
BUY
$4.29 - $5.64 $154,933 - $203,688
36,115 Added 70.78%
87,142 $476,000
Q3 2019

Nov 14, 2019
BUY
$4.87 - $7.08 $179,829 - $261,436
36,926 Added 261.87%
51,027 $248,000
Q2 2019

Aug 14, 2019
BUY
$6.6 - $7.8 $9,081 - $10,732
1,376 Added 10.81%
14,101 $98,000
Q1 2019

May 14, 2019
BUY
$5.76 - $8.95 $17,544 - $27,261
3,046 Added 31.47%
12,725 $89,000
Q4 2018

Feb 14, 2019
BUY
$5.26 - $7.97 $28,451 - $43,109
5,409 Added 126.67%
9,679 $57,000
Q3 2018

Nov 14, 2018
SELL
$4.65 - $7.95 $116 - $198
-25 Reduced 0.58%
4,270 $33,000
Q2 2018

Aug 14, 2018
BUY
$5.05 - $6.8 $8,559 - $11,526
1,695 Added 65.19%
4,295 $22,000
Q1 2018

May 15, 2018
BUY
$5.6 - $9.25 $8,960 - $14,800
1,600 Added 160.0%
2,600 $16,000
Q4 2017

Feb 14, 2018
SELL
$6.6 - $7.78 $14,737 - $17,372
-2,233 Reduced 69.07%
1,000 $7,000
Q3 2017

Nov 14, 2017
BUY
$5.75 - $7.75 $7,555 - $10,183
1,314 Added 68.47%
3,233 $23,000
Q2 2017

Aug 14, 2017
BUY
N/A
769 Added 66.87%
1,919 $12,000
Q1 2017

Nov 14, 2017
BUY
N/A
1,150
1,150 $9,000

Others Institutions Holding CRBP

# of Institutions
4
Shares Held
38.7K
Call Options Held
0
Put Options Held
0
View Full List

About Corbus Pharmaceuticals Holdings, Inc.

CRBP Quotes by TradingView
  • Ticker CRBP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 125,268,000
  • Market Cap $1.22B
  • Description
  • Corbus Pharmaceuticals Holdings, Inc., a biopharmaceutical company, focuses on the development of immune modulators for immuno-oncology and fibrosis diseases. It develops lenabasum, an oral molecule that selectively activates cannabinoid receptor type 2 (CB2), which is in Phase II clinical trial to treat systemic lupus erythematosus; CRB-601, an...
More about CRBP
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email